Posted inBiotechnology
Ephrin B3 Fuels Tumor Growth and Inflammation
In a groundbreaking study published recently in Medical Oncology, scientists have uncovered the pivotal role of Ephrin B3, a member…
Posted inBiotechnology
New Insights on Northern White-Breasted Hedgehog Parasites
In a groundbreaking study published in 2025, a team of parasitologists has unveiled new insights into the endoparasitic fauna inhabiting…
Posted inBiotechnology
Hallucinogen Use Linked to Illicit and Prescription Drug Misuse
In recent years, the landscape of substance use in the United States has undergone significant shifts, with hallucinogens emerging from…
Posted inBiotechnology
How Fermentation Transforms Quinoa Protein Properties
In a groundbreaking study that promises to reshape our understanding of plant-based proteins, researchers have unveiled how fermentation intricately alters…
Posted inBiotechnology
Research Reveals Significant Health Insurance Disparities Among Certain Adopted Children
In the United States, the adoption of children is a deeply significant social practice that reshapes countless lives. However, the…
Posted inBiotechnology
UCLA Researchers Engineer Stem Cells to Generate Renewable Cancer-Fighting T Cells
In a groundbreaking advance that could redefine the future of cancer immunotherapy, researchers at UCLA have successfully demonstrated the capacity…
Posted inGenetics
Platinum Pedigree Benchmark Boosts AI Accuracy in Genomic Variant Detection
Recent advances in genome sequencing have improved all aspects of uncovering the human genome. One of the unlocked areas includes…
Posted inGenetics
Repligen Partners with Novasign to Further Advance Bioprocessing Digitalization
Novasign and Repligen entered into a strategic partnership to develop and integrate Novasign’s machine learning and modeling workflow into Repligen…
Posted inResearch
West Virginia University Cancer Institute finds place it belongs in Ryght AI site network
Ryght AI traveled down country roads to find the newest member of its growing clinical trial site collection. West Virginia…
Posted inBiotechnology
Vertex drops aspiring Journavx follower in acute pain after phase 2 failure
Vertex Pharmaceuticals has hit a snag in its efforts to follow up non-opioid pain reliever Journavx (suzetrigine). The Boston-based big…